How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Probiotics for Infants and Pregnant Women Market
- By Product Form: Powder, Capsules, Liquid Drops, Chewable Tablets, Sachets
- By Strain Type: Lactobacillus rhamnosus, Bifidobacterium lactis, Lactobacillus reuteri, Bifidobacterium bifidum, Saccharomyces boulardii
- By Target Consumer: Infants (0-12 months), Pregnant Women, Lactating Mothers
- By Distribution Channel: Pharmacies and Drug Stores, Online Retail, Supermarkets and Hypermarkets, Specialty Stores
- By Application: Digestive Health, Immune Support, Allergy Prevention, Colic Relief
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Powder leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 301 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Probiotics for Infants and Pregnant Women Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Product Form 5
Strain Type 5
Target Consumer 3
Distribution Channel 4
Application 4
Companies profiled
Nestlé S.A.
Danone S.A.
Chr. Hansen Holding A/S
Probi AB
BioGaia AB
Yakult Honsha Co. Ltd.
Lactalis Group
DuPont Nutrition & Health (IFF)
Morinaga Milk Industry Co. Ltd.
Bifodan A/S
Ganeden
Inc. (Kerry Group)
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Nestlé S.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Danone S.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Chr. Hansen Holding A/S
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Probi AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →BioGaia AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Yakult Honsha Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Lactalis Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →DuPont Nutrition & Health (IFF)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Morinaga Milk Industry Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Bifodan A/S
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Ganeden
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Inc. (Kerry Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Jarrow Formulas Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Renew Life
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Nature's Way Products
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Sabinsa Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,625M by 2033 · 6.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Powder40.3
- Capsules13.4
- Liquid Drops17.2
- Chewable Tablets17.0
- Sachets12.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,147M → $2,035M · 7.4%
Europe$799.3M → $1,204M · 5.3%
Asia Pacific$729.8M → $1,278M · 7.3%
Latin America$451.8M → $763.8M · 6.8%
Middle East and Africa$347.5M → $590.1M · 6.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.162026
6.172027
6.192028
6.192029
6.202030
6.212031
6.232032
6.232033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Nestlé S.A.17.1
- Danone S.A.20.5
- Chr. Hansen Holding A/S9.7
- Probi AB6.1
- BioGaia AB12.2
- Yakult Honsha Co. Ltd.6.5
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Form21.6%
Strain Type21.9%
Target Consumer17.9%
Distribution Channel19.2%
Application19.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.7
- Europe20.5
- Asia Pacific21.8
- Latin America13.0
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Nestlé S.A. | 97 | 76 | 82 | 77 | 78 | 87 | 83 |
| Danone S.A. | 84 | 89 | 89 | 73 | 77 | 82 | 82 |
| Chr. Hansen Holding A/S | 73 | 79 | 84 | 68 | 85 | 81 | 78 |
| Probi AB | 59 | 77 | 72 | 82 | 62 | 76 | 71 |
| BioGaia AB | 68 | 62 | 67 | 55 | 61 | 56 | 62 |
| Yakult Honsha Co. Ltd. | 57 | 63 | 63 | 59 | 64 | 70 | 63 |
| Lactalis Group | 60 | 65 | 48 | 49 | 55 | 50 | 55 |
| DuPont Nutrition & Health (IFF) | 40 | 46 | 55 | 52 | 47 | 57 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Nestlé S.A.
- Danone S.A.
- Chr. Hansen Holding A/S
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Nestlé S.A. | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Danone S.A. | ◐ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Chr. Hansen Holding A/S | ◐ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Probi AB | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| BioGaia AB | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Yakult Honsha Co. Ltd. | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| Lactalis Group | − | ✓ | ◐ | ◐ | − | − |
| DuPont Nutrition & Health (IFF) | − | − | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Nestlé S.A.83
2Danone S.A.82
3Chr. Hansen Holding A/S78
4Probi AB71
5Yakult Honsha Co. Ltd.63
6BioGaia AB62
7Lactalis Group55
8DuPont Nutrition & Health (IFF)50
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Nestlé S.A.Danone S.A.Chr. Hansen Holding A/S
Challenger1
Strong scale, closing on the leaders.
Probi AB
Contender2
Focused players with pockets of strength.
BioGaia ABYakult Honsha Co. Ltd.
Niche2
Specialists in a single segment or region.
Lactalis GroupDuPont Nutrition & Health (IFF)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Form in North America, then scale across Probiotics for Infants and Pregnant Women Market — a $295M beachhead inside a $4.85B market.
Beachhead (SOM)$295Mobtainable near-term
Serviceable (SAM)$1.73Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Powder
Best fit — highest urgency & budget in Product Form.
Economic buyer77 fit
Capsules
Strong fit — clear ROI and a fast path to value.
End user70 fit
Liquid Drops
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Strain Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Target Consumer
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Probiotics for Infants and Pregnant Women Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified24%
Evaluation15%
Closed-won8%
$10.1KCAC
$40KLTV
4.0:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Probiotics for Infants and Pregnant Women Market is a high-growth opportunity — $2.17B by 2033, compounding at 10.7%.
TAM · 2025$957Mtoday
TAM · 2033$2.17Bforecast
CAGR10.7%2027–2033
Cumulative$13.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.17BTotal addressable market
SAM$881MServiceable available market
SOM$173MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.7% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.17BLarge & growingTAM by 2033 at 10.7% CAGR
$881MServiceable nowreachable with today’s model
$173MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.69BBear7.0% CAGR
$2.17BBase10.7% CAGR
$2.77BBull14.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Strain Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Probiotics for Infants and Pregnant Women Market — a $979M market by 2033. Plan: grow share from 11.7% to 18.7%.
Market size · 2033$979Mtotal addressable
Market CAGR3.9%2027–2033
Target share18.7%from 11.7% today
Revenue ambition$183Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.7% | 18.7% | On track |
| Revenue | $113M | $183M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.0% | 39.7% | At risk |
| Customer retention | 90.2% | 94.8% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Strain Type capability
A defensible second engine — invest in Strain Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Strain Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $23M capacity & capability investment
- Greenlight bolt-on M&A in Strain Type
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Probiotics for Infants and Pregnant Women Market conversation — a $10.2B market you can size, segment and defend in minutes.
Market size · 2033$10.2Btotal opportunity
Growth9.0%CAGR to 2033
Addressable buyers1,134+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 3 mopayback period
$90K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Nestlé S.A.Danone S.A.Chr. Hansen Holding A/SProbi ABBioGaia ABYakult Honsha Co. Ltd.Lactalis GroupDuPont Nutrition & Health (IFF)+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Probiotics for Infants and Pregnant Women Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Probiotics for Infants and Pregnant Women Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Probiotics for Children Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportProbiotics Dietary Supplements Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportProbiotics Detection Service Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportProbiotics Capsule and Powder Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportProbiotics Based Dietary Supplement Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportProbiotic Pills Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportProbiotic Manufacturing Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportProbiotic Lozenges Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportProbiotic Health Supplements Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportProbiotic Complex Supplement Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportProbiotic Chewable Tablets Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportProbiotic Capsules Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.